Ascendis Pharma A/S (ASND)

ASND trades at $192.74, 7.1% above the near-term max pain of $180 expiring Sep 19, 2025 (21 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($115-$260), indicating stable market expectations. Key magnetic zone at 180 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ASND shows stable levels around 180.00, reflecting balanced market expectations. The 81% spread signals divergent expectations across timeframes. Most levels below 192.74 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.